By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001



Company News
Amid Restructuring and Lawsuits, Novartis AG (NVS) Indicates It Might Sell $14 Billion Roche (RHHBY) Stock Without a Premium 5/25/2016 7:21:23 AM
PDL BioPharma (PDLI) Bags Novartis AG (NVS)'s Hypertension Drugs Via $107 Million Investment in Noden Pharma 5/25/2016 6:19:23 AM
Novartis AG (NVS) CEO Attempts to Rebuild as Seven Execs Jump Ship in the Space of Five Months 5/24/2016 6:54:23 AM
Novartis AG (NVS)'s Entresto Boosted by Class I Recommendation in U.S., EU Heart Failure Guidelines 5/23/2016 6:05:12 AM
Novartis AG (NVS) Announces Investment In FortiHFy Clinical Program Of Entresto And Heart Failure 5/20/2016 3:05:18 PM
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance 5/19/2016 6:43:57 AM
Novartis AG (NVS)'s Pharma Head Exits as Drug Business is Split into Two 5/18/2016 6:22:10 AM
Novartis AG (NVS) Ponders Over Using a Medical Device-Like Sales Model for Experimental Cancer Therapy 5/17/2016 6:57:45 AM
BioIntegrator, LLC Announces The Second Market Registration Of Nescler, A First Generic Of The Novartis AG (NVS) MS Blockbuster Gilenya 5/16/2016 7:39:24 AM
Teva (TEVA)'s European Portfolio Attracts Interest from Mylan (MYL) and Novartis AG (NVS), Sale Could Bring in $1.5 to $2 Billion 5/16/2016 7:13:18 AM